Maurice R. Ferré, M.D.,
President, Chief Executive Officer and Chairman of the Board of Directors

Dr. Maurice R. Ferré is the founding President and Chief Executive Officer and current Chairman of the Board of Directors of MAKO Surgical Corp. In June 2007, he received the Ernst & Young Entrepreneur of the Year 2007 award for emerging companies in Florida. In 1993, Dr. Ferré founded Visualization Technology, Inc., a medical device company for image-guided surgery, where he served as Chief Executive Officer until April 2002 when Visualization Technology was acquired by GE Healthcare, the healthcare division of the General Electric Company.

Dr. Ferré served as Vice President of Strategic Development for GE Navigation, a Division of GE Healthcare from April 2002 until April 2004. In May 2004, Dr. Ferré became the Chief Executive Officer of Z-KAT, Inc., a surgical navigation device company, which eventually spun-off the orthopedic robotics segment that became the basis for the founding of MAKO Surgical. He holds an M.D. and a Master's degree in Public Health from Boston University.



Fritz L. LaPorte,
Senior Vice President of Finance and Administration, Chief Financial Officer and Treasurer

Fritz LaPorte, Senior Vice President of Finance and Administration, Chief Financial Officer and Treasurer, has been with MAKO Surgical Corp. since its inception in November 2004. Beginning in 2001, Mr. LaPorte served as Chief Financial Officer of Z-KAT, Inc., a surgical navigation device company. Prior to joining Z-KAT, Mr. LaPorte served as the Director of Finance for Holy Cross Hospital, a 580-bed acute facility in Ft. Lauderdale, Florida, from 1997 to 2000.

In addition, he also served as a Senior Auditor in the Healthcare Group of Ernst and Young LLP from 1993 to 1997. Mr. LaPorte received a B.B.A. degree in accounting from Florida Atlantic University and is a Certified Public Accountant.



Rony A. Abovitz,
Senior Vice President and Chief Technology Officer

Rony Abovitz, Senior Vice President and Chief Technology Officer, has been with MAKO Surgical Corp. since its inception in November 2004. Mr. Abovitz is responsible for leading the development of MAKO Surgical's technology and product portfolio, including an IP portfolio of more than 240 patents held by the company. His background includes orthopedic and cardiovascular implant development, including involvement with medical robotics and computer-assisted technologies since 1995. Mr. Abovitz was also the co-founder of Z-KAT, Inc., a surgical navigation device company, which eventually spun-off the orthopedic robotics segment that became the basis for the founding of MAKO Surgical.

From its inception, Mr. Abovitz held various executive positions, including Chief Executive Officer and Chief Technology Officer. From 1994 to 1996, Mr. Abovitz worked as a research and development engineer for Lima Orthopedics, Inc. developing orthopedic implants. Mr. Abovitz was also named a 2005 Technology Pioneer by the World Economic Forum for his work on computer-assisted technologies for minimally invasive surgery. He holds a B.S. in mechanical engineering and a M.S. in biomedical engineering from the University of Miami.



Menashe R. Frank, Esq.,
Senior Vice President,
General Counsel and Secretary

Menashe Frank, Senior Vice President, General Counsel and Secretary, has been with MAKO Surgical Corp. since its inception in November 2004. From July 2004 until the formation of MAKO Surgical Corp., Mr. Frank was a legal consultant to Z-KAT, Inc. Mr. Frank was previously a member of the corporate, securities and finance groups of Hogan & Hartson LLP, where he served as outside corporate counsel for Z-KAT, Inc., from 2001 to 2004.

Mr. Frank was a corporate associate at the law firm of Baker & McKenzie from 2000 to 2001. From 1998 to 2000, Mr. Frank served as Chief Legal Officer for Enticent.com, Inc., a marketing technology enterprise. He was an associate in the business finance and restructuring department of the law firm of Weil, Gotshal & Manges LLP from 1996 to 1998. Mr. Frank holds a B.A. in political science from American University and a J.D. from the University Of Miami School Of Law, where he graduated magna cum laude.



Duncan H. Moffat,
Senior Vice President of
Operations

Duncan H. Moffat, Senior Vice President of Operations, has been with us since April 2008. From 2001 to 2008, Mr. Moffat served as VP of Operations for the nuclear medicine business of Philips Medical Systems, a worldwide manufacturer of medical imaging equipment. From 1998 to 2001, Mr. Moffat served as Vice President of Operations for Lumisys, a start-up company providing digital x-ray products that was sold to Eastman Kodak in 2001. Beginning in 1982, Mr. Moffat held various positions with the Lucas companies, first with two Lucas affiliates in England, followed by a position as project manager with Lucas Control Systems Products, Hampton, Virginia, and then by a position as Director of Operations with Lucas Deeco Systems, Hayward, California, from 1995 to1998. Mr. Moffat holds a Bachelor of Science in Electrical and Electronic Engineering from Strathclyde University, Glasgow, Scotland.



Steven J. Nunes,
Senior Vice President of Sales and Marketing
 
Steve Nunes, Senior Vice President of Sales and Marketing, has been with MAKO Surgical Corp. since May 2006. In 2002, prior to joining MAKO, Mr. Nunes served as Director of Commercialization for GE Healthcare. In 1996, Mr. Nunes joined Visualization Technology, Inc., a medical device company for image-guided surgery. There he was Vice President of Sales and Marketing until April 2002, when Visualization Technology was acquired by GE Healthcare, the healthcare division of the General Electric Company.

In 1990, Mr. Nunes established SJN Medical Inc., an independent distributor for a wide range of surgical endoscopy products, where he served as President until the company was acquired in 1996. Mr. Nunes received a B.A. degree in broadcast journalism from the University of Massachusetts-Amherst.



Benny Hagag,
Vice President of Business Development

Benny Hagag, Vice President of Business Development, has been with MAKO Surgical Corp. since its inception in November 2004. Mr. Hagag previously served as the Engineering Manager for Z-KAT, Inc., leading the development of computer assisted surgery products for orthopedic and neurosurgical procedures. From 2000 to 2002, Mr. Hagag served as the Mechanical Systems Engineering Manager for GE CT/PET System, leading the development and rapid design transfer process to enable sales of fifty systems in the first twelve months of commercial sales.

In 1997, Mr. Hagag became the Team Leader for Mechanical Engineering at Elgems and Elscint in the nuclear and functional imaging business, which was later acquired by GE. Mr. Hagag was also previously responsible for the mechanical systems of the F-16 fighter aircraft and the development of MRPV (mini remotely-piloted vehicle) for the Israeli Air Force. Mr. Hagag holds a BSc. in aerospace engineering and a M.B.A. from Technion University in Israel.



William F. Tapia,
Vice President of Regulatory, Quality and Clinical Affairs and Management Representative

William Tapia, Vice President of Regulatory, Quality and Clinical Affairs, has been with MAKO Surgical Corp. since its inception in November 2004. In 1997, Mr. Tapia co-founded Z-KAT, Inc., and served as a key executive leading the regulatory affairs and quality assurance departments until November 2004. He established Z-KAT's Quality System and obtained ISO 9001 and ISO 13485 certification. Mr. Tapia has a B.S. in mathematics from Jacksonville University and an M.S. in biomedical engineering from the University of Miami.

S. Morry Blumenfeld, Ph.D. has served as one of our directors since July 2005. In 2003, Mr. Blumenfeld founded Meditech Advisors LLC and Meditech Advisors Management LLC, a general partner of Ziegler Meditech Equity Partners, LP, a private equity fund specializing in investments in healthcare and medical device companies. In April 2004, Mr. Blumenfeld retired as Managing Director of GE Medical Systems in Israel after 31 years with the company, where he initiated both GE’s CT and MR business lines. Currently, he serves on the board of directors of a number of medical device and technology companies, including Oridion Systems Ltd. and several private companies. Mr. Blumenfeld holds a B.A.Sc in Engineering Physics and Ph.D. in Molecular Physics from the University of Toronto.

Gerald A. Brunk has served as one of our directors since October 2006. Mr. Brunk is a Managing Director at Lumira Capital Corp., a venture capital firm, which he joined in July 2002. From 2000 to 2002, Mr. Brunk was the Chief Operating Officer of ActiveCyte, Inc., a bioinformatics software company. During his career, Mr. Brunk has also served as a Manager in the healthcare practice of The Boston Consulting Group and as a member of the investment banking group at Credit Suisse First Boston. Currently, Mr. Brunk serves on the board of directors of ActivBiotics, Inc. and Cardiac Dimensions, Inc. Mr. Brunk holds a B.A. from the University of Virginia and an M.B.A. from Stanford University Graduate School of Business.

Marcelo G. Chao has served as one of our directors since January 2007. He is a Managing Director at The Exxel Group, an affiliate of MK Investment Company, which he joined in March 2000. From 1995 to 2000, Mr. Chao was a Partner at Hermes Management Consulting. From 1992 to 1995, Mr. Chao was Vice-president of Citibank in Buenos Aires, Argentina, and from 1991 to 1992 he worked for McKinsey & Company. Currently, Mr. Chao serves on the board of directors of several portfolio companies. Between November 2002 and December 2006, Mr. Chao also served on the Latin American and Caribbean board of MasterCard International. Mr. Chao holds a B.S. in business administration from Universidad Católica Argentina and is a Certified Public Accountant.

Christopher C. Dewey has served as one of our directors since our inception in November 2004. Since January 2007, Mr. Dewey has served as Vice-Chairman of the board of directors of National Holdings Corporation, a financial services organization operating through its subsidiary, National Securities. Mr. Dewey also serves as acting Chief Executive Officer and director of Z-KAT, Inc. Mr. Dewey has over 25 years experience on Wall Street, most recently as Executive Vice President of Jefferies & Company, Inc. from 1994 to December 2006. Mr. Dewey co-founded several companies, including Robotic Ventures LLC, Bonds Direct Securities LLC and Cannon Group Inc., a motion picture company that went public in 1972. Mr. Dewey holds an MBA from The Wharton School of the University of Pennsylvania.

Charles W. Federico has served as one of our directors since June 2007. From 2001 to April 2006, Mr. Federico served as President and Chief Executive Officer of Orthofix International N.V. and; from 1996 to 2001, he served as President of Orthofix Inc. From 1985 to 1996, Mr. Federico was President of Smith & Nephew Endoscopy (formerly Dyonics, Inc.). From 1981 to 1985, Mr. Federico served as Vice President of Dyonics. Previously he held management and marketing positions with General Foods Corporation, Puritan Bennett Corporation and LSE Corporation. Mr. Federico is a Trustee of the Orthopaedic Research and Education Foundation and a director of Orthofix International N.V., SRI/Surgical Express, Inc., BioMimetic Therapeutics, Inc. and Alveolus, Inc. Mr. Federico holds a B.S. in marketing from Fordham University.

John G. Freund, M.D. has been a Managing Director of Skyline Ventures since 1997. Earlier in his career he held various positions at Acuson Corporation, a medical device company, including Executive Vice President. He was the co-founder of the Healthcare Group in the Corporate Finance Department of Morgan Stanley & Co., Inc., and was the original healthcare partner at Morgan Stanley Venture Partners. In 1995, Dr. Freund co-founded Intuitive Surgical, Inc., a medical device company, and served on Intuitive's board of directors until March 2000. Dr. Freund also serves on the board of directors of Hansen Medical, Inc., XenoPort Inc., MAP Pharmaceuticals, Inc., the New Economy Fund and the SmallCap World Fund, as well as a number of private companies. He received an MD from Harvard Medical School in 1980 and an MBA from Harvard Business School in 1982, where he was a Baker Scholar.

Frederic H. Moll, M.D. has served as one of our directors since August 2007. In September 2002, Mr. Moll co-founded Hansen Medical, Inc. and has served as its Chief Executive Officer and a director. In November 1995, Dr. Moll co-founded Intuitive Surgical Inc., a medical device company, and served as its first Chief Executive Officer and later, its Vice President and Medical Director until September 2003. In 1989, Dr. Moll co-founded Origin Medsystems, Inc., a medical device company, which later became an operating company within Guidant Corporation, a medical device company, following its acquisition by Eli Lilly in 1992. Dr. Moll served as Medical Director of Guidant’s surgical device division until November 1995. Dr. Moll holds a B.A. from the University of California, Berkeley, an M.S. from Stanford University and an M.D. from the University of Washington School of Medicine.

William D. Pruitt has served as one of our directors since June 2008. Mr. Pruitt is the President of Pruitt Enterprises, LP. From 1980 to 1999, Mr. Pruitt was the Managing Partner for Arthur Andersen LLP's Florida, Caribbean and Venezuela operations. During his career, Mr. Pruitt has served on the board of directors as a Chairman of the audit committee for several companies. Mr. Pruitt has been a board member of The PBSJ Corporation since July 2005, and has been the Chairman of the company's audit committee since 2003. Mr. Pruitt served as Chairman of the audit committee of KOS Pharmaceuticals, Inc., a fully integrated specialty pharmaceutical company until its sale in 2006. He was also Chairman of the audit committee for Adjoined Consulting, Inc., a full-service management consulting firm, until it was merged into Kanbay International, a global consulting firm in February 2006. Mr. Pruitt has a Bachelor of Business Administration from the University of Miami and is a Certified Public Accountant (inactive).

John J. Savarese, M.D. is a Managing Director at Montreux Equity Partners. Dr. Savarese’s clinical training in Orthopedic and General Surgery was gained at The Hospital for Special Surgery and Cornell University Medical Center. Dr. Savarese has worked in the Life Sciences divisions at Credit Suisse First Boston and Merrill Lynch and held management positions at NeurogesX. He received an MD from Duke University Medical School and MBA from Stanford University.